Kathmere Capital Management, LLC

Position in BMY — Bristol Myers Squibb Co

CIK 1794543 WAYNE, PA

Position in BMY

as of Jun 30, 2026 · filed Jul 29, 2026 Compact

Position Value

$2,143,291

+$737,788 QoQ

Shares Held

37,197

+60.5% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.34%

of 13F equity value

Holder Rank

#807

of 2,514 holders

Holding Since

Sep 2020

14 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Kathmere Capital Management, LLC holds $38,480,404 across 14 Drug Manufacturers - General names. BMY ranks #6 (5.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	46,204	$11,734,429
2	LLY	ELI LILLY & Co	4,626	$5,548,563
3	MRK	Merck & Co., Inc.	30,944	$3,976,304
4	NVS	Novartis AG	22,990	$3,602,992
5	GILD	Gilead Sciences, Inc.	26,787	$3,384,269
6	BMY	Bristol Myers Squibb Co This page	37,197	$2,143,291
7	ABBV	AbbVie Inc.	7,045	$1,772,803
8	BIIB	Biogen Inc.	7,285	$1,573,997

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,143,291	37,197	+60.5%	Shares	Sole	2026-07-29
2026-03-31	$1,405,503	23,174	+125.1%	Shares	Sole	2026-04-28
2025-12-31	$555,258	10,294	+90.7%	Shares	Sole	2026-01-13
2025-09-30	$243,404	5,397	-41.6%	Shares	Sole	2025-10-22
2025-06-30	$428,089	9,248	-3.4%	Shares	Sole	2025-07-16
2025-03-31	$583,918	9,574	-10.0%	Shares	Sole	2025-05-01
2024-12-31	$601,685	10,638	+33.3%	Shares	Sole	2025-01-14
2024-09-30	$412,988	7,982	+94.9%	Shares	Sole	2024-10-15
2024-03-31	$222,126	4,096	+14.3%	Shares	Sole	2024-04-16
2023-06-30	$229,068	3,582	+2.0%	Shares	Sole	2023-07-11
2023-03-31	$243,416	3,512	-21.6%	Shares	Sole	2023-04-20
2022-12-31	$322,407	4,481	+77.0%	Shares	Sole	2023-01-24
2020-12-31	$156,997	2,531	0.0%	Shares	Sole	2021-02-16
2020-09-30	$152,593	2,531	—	Shares	Sole	2020-11-20
No filing history on record for this holder in this stock.